scispace - formally typeset
F

Fuat Kurbanov

Researcher at Nagoya City University

Publications -  61
Citations -  3248

Fuat Kurbanov is an academic researcher from Nagoya City University. The author has contributed to research in topics: Hepatitis B virus & Genotype. The author has an hindex of 34, co-authored 61 publications receiving 3086 citations. Previous affiliations of Fuat Kurbanov include Rega Institute for Medical Research & Academy of Sciences of Uzbekistan.

Papers
More filters
Journal ArticleDOI

A Genetic Variant of Hepatitis B Virus Divergent from Known Human and Ape Genotypes Isolated from a Japanese Patient and Provisionally Assigned to New Genotype J

TL;DR: Hepatitis B virus (HBV) of a novel genotype (J) was recovered from an 88-year-old Japanese patient with hepatocellular carcinoma who had a history of residing in Borneo during the World War II and may help to trace the origin of HBV and merits further epidemiological surveys.
Journal ArticleDOI

Geographical and genetic diversity of the human hepatitis B virus.

TL;DR: This review summarises the recent publications on the geographical distribution of genetic variants of HBV, and proposes updated criteria for the identification of new genotypes and subgenotypes of the virus.
Journal ArticleDOI

Molecular identification of hepatitis B virus genotypes/subgenotypes: revised classification hurdles and updated resolutions.

TL;DR: This review article aimed at highlighting potential pitfalls in genetic and phylogenetic analyses of HBV and suggest novel terms for HBV classification, including the term "immigro-subgenotype" to distinguish exotic (sub)genotypes from native ones and "recombino- subgenotype", which is proposed for many strains misclassified due to genetic differences resulting from recombination.
Journal ArticleDOI

Specific mutations in enhancer II/core promoter of hepatitis B virus subgenotypes C1/C2 increase the risk of hepatocellular carcinoma

TL;DR: The data indicate that T1653 and/or V1753 mutations in addition to T1762/A1764 are differently associated with HCC in context of HBeAg status among HBV/C1/Cs and C2/Ce-carriers.